People

Ronald Perelman

Ronald Perelman

Formal First Name
Ronald
Link
Dates
1943 - present

Ronald Perelman is a renowned investor, innovator, and business visionary who has built, owned and run some of the largest and most iconic companies in the world. He is the Chairman and CEO of MacAndrews & Forbes Incorporated, a private holding company that owns and operates a diversified portfolio of public and private companies. He earned a reputation in the 1980s as one of the era's fiercest corporate raiders. His most-high profile acquisition is the multinational cosmetics, skin care, and personal care company Revlon. In addition to being a business leader, Perelman is recognized as a major supporter of many of the country's most prominent cultural, educational and medical institutions. He is also known for his vast art collections including the works of Andy Warhol, Ty Twombly, Pablo Picasso and Jean-Michael Basquiat.

CURRENT AFFILIATIONS


MACANDREWS & FORBES


REVLON

  • Perelman was once America's wealthiest businessman shortly after he acquired cosmetics company Revlon for $2.7 billion in 1985.

  • His investor's Revlon shares, which he used as collateral for loans, have taken a hit in recent years owing in part to the Covid-19 pandemic.


ART

  • Perelman is known for his vast art collections including the works of Andy Warhol, Ty Twombly, Pablo Picasso and Jean-Michael Basquiat.

  • He recently offloaded 71 works valued at $963 million between March of 2020 and January of 2022. 

  • Among the more than two dozen artists represented in the sales were 20th-century icons like Roy Lichtenstein, Ellsworth Kelly, Jackson Pollock, Jasper Johns, Ed Ruscha and Mark Rothko.


PHILANTHROPY

  • The Ronald O. Perelman Center for Emergency Services at NYU Langone Medical Center helps meet the growing need for emergency care in NYC.

  • The Perelman Center for Political Science and Economics fosters the teaching and research required to develop positions on national and international matters. 

  • His commitment to cutting-edge health research has contributed to life-changing advancements for patients in New York and around the world.